PITX1 Is a Regulator of TERT Expression in Prostate Cancer with Prognostic Power

SIMPLE SUMMARY: Most prostate cancer is of an indolent form and is curable. However, some prostate cancer belongs to rather aggressive subtypes leading to metastasis and death, and immediate therapy is mandatory. However, for these, the therapeutic options are highly invasive, such as radical prosta...

Descripción completa

Detalles Bibliográficos
Autores principales: Poos, Alexandra M., Schroeder, Cornelia, Jaishankar, Neeraja, Röll, Daniela, Oswald, Marcus, Meiners, Jan, Braun, Delia M., Knotz, Caroline, Frank, Lukas, Gunkel, Manuel, Spilger, Roman, Wollmann, Thomas, Polonski, Adam, Makrypidi-Fraune, Georgia, Fraune, Christoph, Graefen, Markus, Chung, Inn, Stenzel, Alexander, Erfle, Holger, Rohr, Karl, Baniahmad, Aria, Sauter, Guido, Rippe, Karsten, Simon, Ronald, Koenig, Rainer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909694/
https://www.ncbi.nlm.nih.gov/pubmed/35267575
http://dx.doi.org/10.3390/cancers14051267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909694/
https://www.ncbi.nlm.nih.gov/pubmed/35267575
http://dx.doi.org/10.3390/cancers14051267

Ejemplares similares